Drug-induced hepatotoxicity in children. Where we are and where were are going;Toxicidad hepática por fármacos. Dónde estamos y hacia dónde caminamos

Anales Espanoles de Pediatria

Volumn 56, Issue 5, 2002, Pages 434-442

  Peire M A ^a   Lucena, M I ^a   Ruiz Extremera, A ^a   Jara, P ^a   Romero Gonzalez J ^a   Andrade, R J ^a  

^a Facultad de Medicina   (Spain)

Author keywords

Hepatotoxicity; Pediatric age group; Registry

Indexed keywords

DRUG;

CHILD; CHILD DEVELOPMENT; CHILD GROWTH; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MONITORING; HIGH RISK POPULATION; HUMAN; LIVER TOXICITY; PHARMACODYNAMICS; PHARMACOKINETICS; REVIEW; HEALTH SURVEY; TOXIC HEPATITIS;

CHILD; ENGLISH ABSTRACT; HEPATITIS, TOXIC; HUMAN; POPULATION SURVEILLANCE; HUMANS;

EID: 0036022171     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Drug trials in children: Problems and the way forward
2. Unlicensed and off label drug use in neonates
3. Survey of unlicensed and off label drug use in paediatric wards in European countries
4. Licensing of medicines
5. Use of nimesulide in children
6. Parenteral opinion about biomedical research in children in Tours, France
7. Drug toxicity and surveillance in children
8. Metabolic acidosis in fatal miocardial failure after propofol infusion in children: Five case reports
9. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
10. Epidemiologic evaluation of drug use in children
11. Children are not small adults
12. Status of new medicines approved by the European Medicines Evaluation Agency regarding pediatric use
13. Acute monitoring of adverse drug reactions in children
14. Exploración del hígado
15. Hepatopatías agudas. Hepatitis víricas
16. Algunas peculiaridades de la farmacoterapia en el período neonatal
17. Pharmacokinetic and Pharmacodynamic data collection in children and neonates. A quiet frontier
18. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
19. a Ontogeny and drug disposition
20. Fundamentos del tratamiento de las enfermedades en niños y adolescentes
21. Pharmacovigilance chez l'enfant
22. Salicylate intoxication using a skin ointment
23. Therapeutic misadventures with acetaminophen: Hepatotoxicity after multiple doses in children
24. Acetaminophen intoxication during treatment: What you do not know can hurt you
25. Halothane hepatitis in children
26. Valproic acid hepatic fatalities. A retrospective review
27. Drug-induced hepatotoxicity: Pharmacokinetic perspectives and strategies for risk reduction
28. Suspected carabamazepine-induced hepatotoxicity
29. Pemoline-associated hepatic failure: A critical analysis of the literature
30. Case study: Risperidone-induced hepatotoxicity in pediatric patients
31. Drug utilization in non-hospitalised newborns infants and children
32. Children as participants in medical research
33. Drug trials in children: Ethical, legal and practical issues
34. Farmacología pediátrica, ¿Va la terapéutica infantil precedida de una adecuada investigación?
35. Percutaneous absorption and skin necrosis in a preterm infant
36. Liver complications of pediatric parenteral nutrition
37. Pathologie néonatales et périnatale
38. The child and clinical research
39. Hepatitis tóxicas
40. Hepatologia clínica y farmacoepidemiología: Un enfoque multidisciplinario pendiente
41. Utilidad de los registros de hepatotoxicidad por fármacos
42. Comparison of two clinical scales for causality assessment in hepatotoxicity